Vivos Therapeutics (VVOS) Gross Profit Growth (1y) (2021 - 2026)
Vivos Therapeutics (VVOS) Gross Profit Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 15.59% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 17.10% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 10.88% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 12.38% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 13.54% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 20.50% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 9.82% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 4.20% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 8.95% |
| 10 | Vivos Therapeutics | 4.94 Mn | 3.14 Mn | 2.95 Mn | 39.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 102.72% |
| Dec 31, 2025 | 42.49% |
| Sep 30, 2025 | 68.68% |
| Jun 30, 2025 | -20.41% |
| Mar 31, 2025 | -22.10% |
| Dec 31, 2024 | 0.38% |
| Sep 30, 2024 | 33.60% |
| Jun 30, 2024 | 26.36% |
| Mar 31, 2024 | -17.12% |
| Dec 31, 2023 | -12.37% |
| Sep 30, 2023 | -30.01% |
| Jun 30, 2023 | -18.93% |
| Mar 31, 2023 | -8.39% |
| Dec 31, 2022 | -23.27% |
| Sep 30, 2022 | -21.58% |
| Jun 30, 2022 | -28.59% |
| Mar 31, 2022 | -5.17% |
| Dec 31, 2021 | 15.58% |
| Sep 30, 2021 | 23.26% |
| Jun 30, 2021 | 32.93% |